UNDERWRITING AGREEMENT between IceCure Medical Ltd. and as Representative of the Several UnderwritersUnderwriting Agreement • December 3rd, 2021 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York
The undersigned, IceCure Medical Ltd., a company formed under the laws of the State of Israel (the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
ICECURE MEDICAL LTD. Up to US$9,700,000 of Ordinary Shares EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • January 12th, 2024 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York
This Equity Distribution Agreement (this “Agreement”) is entered into between IceCure Medical Ltd., a company formed under the laws of the State of Israel (the “Company”) and Maxim Group LLC (the “Agent”), as sales agent, with respect to the proposed issue and sale by the Company, through the Agent, of ordinary shares of the Company, no par value per share (the “Ordinary Shares”), having an aggregate offering price of up to US$9,700,000 (the Ordinary Shares subject to this Agreement being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 23rd, 2022 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 21, 2022, between IceCure Medical Ltd., a company formed under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 10th, 2021 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 26, 2021, between IceCure Medical Ltd., an Israeli corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
IceCure Medical Ltd. Attention: Mr. Eyal ShamirIceCure Medical Ltd. • December 23rd, 2022 • Surgical & medical instruments & apparatus • New York
Certain confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly...Distribution Agreement • July 23rd, 2021 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • Delaware
This Distribution Agreement (“Agreement”) is entered into as of August 29, 2019 (the “Effective Date”) by and between IceCure Medical Ltd., a corporation having its principal office at Haeshel 7, Caesarea, 3079504, , Israel (“IceCure”) and Terumo Corporation, having its registered place of business at 2-44-1 Hatagaya, Shibuya-ku Tokyo, 151-0072 Japan (“Terumo”). IceCure and Terumo may be referred to individually as a “Party” and collectively as the “Parties”.
EXCLUSIVE DISTRIBUTION AGREEMENT AMONG SHANGHAI MEDTRONIC ZHIKANG MEDICAL DEVICES CO., LTD. AND ICECURE (SHANGHAI) MEDTECH CO., LTD. AND BEIJING TURING MEDICAL TECHNOLOGY CO., LTD.Exclusive Distribution Agreement • September 2nd, 2022 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus
Shanghai Medtronic Zhikang Medical Devices Co., Ltd., with registered address Room 3048, 3049 East side, 3rd Floor, Factory 12, No.1566 Xinyang Road, China (Shanghai) Pilot Free Trade Zone Lin-gang Special Area (“MDT”);
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • September 2nd, 2022 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus
This Exclusive Distribution Agreement (this “Agreement”), effective as of the 12th day of June, 2022 (the “Effective Date”), is entered into by and among IceCure Medical Ltd., an Israeli company, with offices at 7 Ha’Eshel St., Caesarea, Israel (“Supplier”); IceCure (Shanghai) MedTech Co., Ltd., with registered address Room 213, 2nd Floor, Building 19, No.60 Zhonghui Road, Minhang District, Shanghai (“IceCure”), and Beijing Turing Medical Technology Co., Ltd., with registered address Room 401, 4th Floor, Building 8, No. 87 Hongan Road, Fangshan District, Beijing (“Turing” or “Distributor”). Supplier, IceCure and Turing are sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”.
IceCure Medical, Shanghai Medtronic & Turing Medical Sign Distribution Agreement in Mainland ChinaIceCure Medical Ltd. • June 13th, 2022 • Surgical & medical instruments & apparatus
· Shanghai Medtronic to exclusively distribute IceSense3 cryoablation systems with a minimum purchase target of $3.5 million in the first 3 years of the contract
